Glypican-1(GPC-1) is a potential biomarker for pancreatic cancer diagnosis [99], and human leucine rich alpha-2-glycoprotein 1 (LRG1) in urinary sEVs is a potential biomarker for diagnosis of NSCLC [100]. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.